HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ayling, C. M. Articles by Schulster, D. Search for Related Content PubMed Articles by Ayling, C. M. Articles by Schulster, D.

The studies describe alterations after hypophysectomy in the proportion of the type-1 and type-2 fibres in rat skeletal muscles, and the effects of replacement treatment with pituitary human (h) GH.

Cytochemical analysis of myosin ATPase, succinate dehydrogenase and lactate dehydrogenase activities in sections of rat hind limb muscles were used as markers of fibre type and revealed that hypophysectomy reduced the proportion of type-1 fibres by 50% in soleus and in extensor digitorum longus muscles. This reduction in the proportion of type-1 fibres was accompanied by the appearance of transitional fibres (type 2C/1B).

Following seven daily injections of hGH (60 mIU/day) to hypophysectomized rats, the proportion of type-1 fibres in both soleus and in extensor digitorum longus was increased with a concomitant reduction in the number of transitional fibres. After 11 days of treatment, all these transitional fibres had reverted back to type-1 fibres. Only hGH was observed to elicit this effect; injections of other pituitary hormones had no effect on the proportions of these transitional fibres.

These alterations in fibre type occurred more rapidly than the changes reported after prolonged electrical stimulation of muscle or following extended exercise.

These findings suggest that hypophysectomy and GH injection can result in a rapid alteration in the fibre composition of skeletal muscle, which may have important implications in terms of the resistance to fatigue and speed of contraction of the muscle.

Journal of Endocrinology (1989) 123, 429–435

This article has been cited by other articles:

				I. Pilecka, C. Patrignani, R. Pescini, M.-L. Curchod, D. Perrin, Y. Xue, J. Yasenchak, A. Clark, M. C. Magnone, P. Zaratin, et al. Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth J. Biol. Chem., November 30, 2007; 282(48): 35405 - 35415. [Abstract] [Full Text] [PDF]

				L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults Endocr. Rev., May 1, 2006; 27(3): 287 - 317. [Abstract] [Full Text] [PDF]

				W. Liu, S. G. Thomas, S. L. Asa, N. Gonzalez-Cadavid, S. Bhasin, and S. Ezzat Myostatin Is a Skeletal Muscle Target of Growth Hormone Anabolic Action J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5490 - 5496. [Abstract] [Full Text] [PDF]

				A. H. Casse, D. Desplanches, M. H. Mayet-Sornay, M. Raccurt, S. Jegou, and G. Morel Growth Hormone Receptor Expression in Atrophying Muscle Fibers of Rats Endocrinology, August 1, 2003; 144(8): 3692 - 3697. [Abstract] [Full Text] [PDF]

				I. Sinha-Hikim, J. Artaza, L. Woodhouse, N. Gonzalez-Cadavid, A. B. Singh, M. I. Lee, T. W. Storer, R. Casaburi, R. Shen, and S. Bhasin Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E154 - E164. [Abstract] [Full Text] [PDF]

				M. Katsumata, D. Cattaneo, P. White, K. A. Burton, and M. J. Dauncey Growth Hormone Receptor Gene Expression in Porcine Skeletal and Cardiac Muscles Is Selectively Regulated by Postnatal Undernutrition J. Nutr., October 1, 2000; 130(10): 2482 - 2488. [Abstract] [Full Text]

				Measures of Submaximal Aerobic Performance Evaluate and Predict Functional Response to Growth Hormone (GH) Treatment in GH-Deficient Adults J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4570 - 4577. [Abstract] [Full Text]

				E. Svanberg, L. Powell-Braxton, C. Ohlsson, H. Zachrisson, and K. Lundholm The Role of the Growth Hormone/Insulin-Like Growth Factor I Axis in Stimulation of Protein Synthesis in Skeletal Muscles Following Oral Refeeding Endocrinology, December 1, 1998; 139(12): 4906 - 4910. [Abstract] [Full Text] [PDF]

				J. Svensson, L. Lönn, J.-O. Jansson, G. Murphy, D. Wyss, D. Krupa, K. Cerchio, W. Polvino, B. Gertz, I. Boseaus, et al. Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 362 - 369. [Abstract] [Full Text]

				R. Bottinelli, M. Narici, M. A. Pellegrino, B. Kayser, M. Canepari, G. Faglia, and A. Sartorio Contractile Properties and Fiber Type Distribution of Quadriceps Muscles in Adults with Childhood-Onset Growth Hormone Deficiency J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4133 - 4138. [Abstract] [Full Text] [PDF]

				G. Johannsson, G. Grimby, K. S. Sunnerhagen, and B.-A. Bengtsson Two Years of Growth Hormone (GH) Treatment Increase Isometric and Isokinetic Muscle Strength in GH-Deficient Adults J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2877 - 2884. [Abstract] [Full Text] [PDF]

				G. Johannsson, P. Marin, L. Lonn, M. Ottosson, K. Stenlof, P. Bjorntorp, L. Sjostrom, and B.-A. Bengtsson Growth Hormone Treatment of Abdominally Obese Men Reduces Abdominal Fat Mass, Improves Glucose and Lipoprotein Metabolism, and Reduces Diastolic Blood Pressure J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 727 - 734. [Abstract] [Full Text] [PDF]

				M. E. Coleman, F. DeMayo, K. C. Yin, H. M. Lee, R. Geske, C. Montgomery, and R. J. Schwartz Myogenic Vector Expression of Insulin-like Growth Factor I Stimulates Muscle Cell Differentiation and Myofiber Hypertrophy in Transgenic Mice J. Biol. Chem., May 19, 1995; 270(20): 12109 - 12116. [Abstract] [Full Text] [PDF]